Pfizer has reported quarterly revenue well below Wall Street expectations on falling sales of key brands and generic drugs. The figures underscored its interest in pursuing a $106 billion bid
Pfizer has reported quarterly revenue well below Wall Street expectations on falling sales of key brands and generic drugs. The figures underscored its interest in pursuing a $106 billion bid